Clinical Trial Update: A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight [Phase 3]

View source ↗

Summary

This is a Phase 3 trial sponsored by Novo Nordisk to compare injectable CagriSema with placebo in adults with overweight or obesity; recruitment has not yet beg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 3 | Status: NOT_YET_RECRUITING